Bafnapharm Key Metrics

BSE: 532989 | NSE: BAFNAPH | ISIN: INE878I01022 | Sector: Biotechnology & Drugs

81.74 +1.74 (2.18%)Updated : 25 Nov 2024

Ratios

Return on average equity - 5 year average	9.50
Net Income/employee - trailing 12 month	6,582.52
Revenue/employee - most recent fiscal year	25,30,184.00
Return on investment - most recent fiscal year	8.32
Return on average assets - most recent fiscal year	5.30
Receivables turnover - most recent fiscal year	3.53
Return on investment - trailing 12 month	0.44
Return on average assets - trailing 12 month	0.30
Inventory turnover - most recent fiscal year	3.84
Inventory turnover - trailing 12 month	3.67
Revenue/employee - trailing 12 month	23,21,193.00
Return on average assets - 5 year average	5.45
Net Income/employee - most recent fiscal year	1,21,855.70
Return on average equity - trailing 12 month	0.49
Receivables turnover - trailing 12 month	3.90
Asset turnover - most recent fiscal year	1.10
Asset turnover - trailing 12 month	1.07
Return on average equity - most recent fiscal year	9.52
Return on investment - 5 year average	8.23